Additionally, co-injection of ZIP1-overexpressing PCCAFs did not promote the growth of A549 tumour cells but increased the resistance of these tumour cells to DOX (Supplementary Fig. 6b). The gene discussed is SLC39A1; the disease is neoplasm.